Characteristic | Round 1 | Round 2 | Round 3 |
---|---|---|---|
Participant, n | 82 | 77 | 75 |
Gender, n (%) | |||
Female | 52 (63.4) | 49 (63.6) | 48 (64.0) |
Male | 30 (36.6) | 28 (36.4) | 27 (36.0) |
Continent of residence, n (%) | |||
Europe | 48 (58.5) | 44 (57.1) | 42 (57.3) |
America | 21 (25.6) | 21 (27.3) | 21 (28.0) |
Asia | 10 (12.2) | 9 (11.7) | 7 (10.7) |
Australia | 3 (3.7) | 3 (3.9) | 3 (4.0) |
Professional area, n (%)a | |||
Pharmacist | 35 (42.7) | 34 (42.9) | 33 (44.0) |
Doctor | 28 (34.1) | 27 (33.8) | 26 (34.7) |
Researcher | 26 (31.7) | 25 (32.5) | 25 (33.3) |
Nurse | 6 (7.3) | 6 (7.8) | 6 (8.0) |
Care home staff | 1 (1.2) | 1 (1.3) | 1 (1.3) |
Representative of advocacy groups | 4 (4.9) | 2 (2.6) | 2 (2.7) |
Otherb | 2 (2.4) | 2 (2.6) | 2 (2.7) |
Age, median (range) | 45 (23—74) | 46 (29—74) | 46 (29—74) |